Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19
Allergy · 2024-09 · 79 (9) · 2482-2501
DOI: 10.1111/all.16210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Allergy, online erschienen am 14.07.2024. Verfasst von Bernhard Kratzer und 19 weiteren Autor:innen. Beteiligte Einrichtung: Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Cytokines, Antibodies, Viral. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
SARS‐CoV‐2 has triggered a pandemic and contributes to long‐lasting morbidity. Several studies have investigated immediate cellular and humoral immune responses during acute infection. However, little is known about long‐term effects of COVID‐19 on the immune system.
Methods
We performed a longitudinal investigation of cellular and humoral immune parameters in 106 non‐vaccinated subjects ten weeks (10 w) and ten months (10 m) after their first SARS‐CoV‐2 infection. Peripheral blood immune cells were analyzed by multiparametric flow cytometry, serum cytokines were examined by multiplex technology. Antibodies specific for the Spike protein (S), the receptor‐binding domain (RBD) and the nucleocapsid protein (NC) were determined. All parameters measured 10 w and 10 m after infection were compared with those of a matched, noninfected control group ( n = 98).
Results
Whole blood flow cytometric analyses revealed that 10 m after COVID‐19, convalescent patients compared to controls had reduced absolute granulocyte, monocyte, and lymphocyte counts, involving T, B, and NK cells, in particular CD3 + CD45RA + CD62L + CD31 + recent thymic emigrant T cells and non‐class‐switched CD19 + IgD + CD27 + memory B cells. Cellular changes were associated with a reversal from Th1‐ to Th2‐dominated serum cytokine patterns. Strong declines of NC‐ and S‐specific antibody levels were associated with younger age (by 10.3 years, p < .01) and fewer CD3 − CD56 + NK and CD19 + CD27 + B memory cells. Changes of T‐cell subsets at 10 m such as normalization of effector and Treg numbers, decline of RTE, and increase of central memory T cell numbers were independent of antibody decline pattern.
Conclusions
COVID‐19 causes long‐term reduction of innate and adaptive immune cells which is associated with a Th2 serum cytokine profile. This may provide an immunological mechanism for long‐term sequelae after COVID‐19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Pathophysiology, Infectiology and Immunology, Institute of Immunology, Medical University of Vienna, Vienna, Austria.
- Center for Pathophysiology, Infectiology and Immunology, Department of Pathophysiology and Allergy Research, Medical University of Vienna, Vienna, Austria.
- Laboratory for Immunopathology, Department of Clinical Immunology and Allergology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
- Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
- Department of Transfusion Medicine and Cell Therapy, Medical University of Vienna, Vienna, Austria.
- Center for Public Health, Department for Environmental Health, Medical University of Vienna, Vienna, Austria.
ORCID-Profile: Bernhard Kratzer, Pia Gattinger, Robert B Stieger, Al Nasar Ahmed Sehgal, Inna Tulaeva, Katharina Grabmeier-Pfistershammer, Peter A Tauber, Thomas Perkmann, Ingrid Fae, Sabine Wenda, Michael Kundi, Gottfried F Fischer, Rudolf Valenta, Winfried F Pickl
Zitieren
APA
Kratzer, B., Gattinger, P., Trapin, D., Ettel, P., Körmöczi, U., Rottal, A., Stieger, R. B., Sehgal, A. N. A., Feichter, M., Borochova, K., Tulaeva, I., Grabmeier-Pfistershammer, K., Tauber, P. A., Perkmann, T., Fae, I., Wenda, S., Kundi, M., Fischer, G. F., Valenta, R., & Pickl, W. F. (2024). Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19. Allergy, 79(9), 2482-2501. https://doi.org/10.1111/all.16210
Vancouver
Kratzer B, Gattinger P, Trapin D, Ettel P, Körmöczi U, Rottal A, et al. Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19. Allergy. 2024;79(9):2482-2501. doi:10.1111/all.16210
BibTeX
@article{Kratzer2024,
author = {Kratzer, Bernhard and Gattinger, Pia and Trapin, Doris and Ettel, Paul and Körmöczi, Ulrike and Rottal, Arno and Stieger, Robert B and Sehgal, Al Nasar Ahmed and Feichter, Melanie and Borochova, Kristina and Tulaeva, Inna and Grabmeier-Pfistershammer, Katharina and Tauber, Peter A and Perkmann, Thomas and Fae, Ingrid and Wenda, Sabine and Kundi, Michael and Fischer, Gottfried F and Valenta, Rudolf and Pickl, Winfried F},
title = {Differential decline of SARS‐CoV‐2‐specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID‐19},
journal = {Allergy},
year = {2024},
volume = {79},
number = {9},
pages = {2482--2501},
doi = {10.1111/all.16210}
}
EUVIMED